ANTAGONISTS OF SLC38A9 AND THEIR USE IN THERAPY

TREATMENT OF MULTIPLE SCLEROSIS BY INHIBITION OF ALLOGRAFT INFLAMMATORY FACTOR-1

Use of inhibitors of leukotriene B4 receptor BLT2 for treating asthma

MiR-320e and colorectal cancer

MicroRNA treatment of fibrosis

Compositions and methods for inhibiting expression of CD274/PD-L1 gene

Targeting microRNAs for metabolic disorders

RNA-interference by single-stranded RNA molecules

COMPOSITIONS AND METHODS OF USING SAME FOR CONTROLLING PATHOGENICALLY INFECTED MOSQUITOES

LOW DENSITY LIPOPROTEIN RECEPTOR-MEDIATED siRNA DELIVERY

TREATMENT OF RESISTANT LESIONS

RNAi-mediated inhibition of phosphodiesterase type 4 for treatment of CAMP-related ocular disorders

USE OF TELOMERASE INHIBITORS FOR THE TREATMENT OF MYELOPROLIFERATIVE DISORDERS AND MYELOPROLIFERATIVE NEOPLASMS

RNA interference for the treatment of gain-of-function disorders

EXTRACELLULAR VESICLE METHODS AND COMPOSITIONS

Pharmaceutical combination comprising a CIP2A silencing agent for use in the treatment of a hyperproliferative disorder, preferably one with impaired P53 function

Pdia4 protein as a target for diagnosis, monitoring and treatment of diabetes

Polycomb-associated non-coding RNAs

Compositions and methods to promote erythropoiesis

Oligomeric compounds comprising alpha-beta-constrained nucleic acid

METHODS AND COMPOSITIONS FOR IMMUNE DIS-INHIBITION

MicroRNA-Based Methods and Compositions for the Diagnosis, Prognosis and Treatment of Ovarian Cancer Using a Real-Time PCR Platform

MODULATION OF ANGIOPOIETIN-LIKE 3 EXPRESSION

NEAT1 as a prognostic marker and therapeutic target for prostate cancer

LncRNAs for therapy and diagnosis of angiogenesis

METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES

OLIGOMERIC COMPOUNDS AND COMPOSITIONS FOR USE IN MODULATION OF SMALL NON-CODING RNAS

Oligomeric compounds and compositions for use in modulation of small non-coding RNAs

Chiral design

Artificial mimic miRNA for controlling gene expression, and use of same

SPINAL MUSCULAR ATROPHY TREATMENT VIA TARGETING SMN2 CATALYTIC CORE

Method of treating diabetic nephropathy by administering antibodies to vascular endothelial growth factor B (VEGF-B)

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

Peptides and combination of peptides for use in immunotherapy against non-small cell lung cancer and other cancers

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

Method for treating cancer with an activated T lymphocyte that selectively recognizes a cancer cell consisting of specific peptide

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

SPECIFIC VIRUS-LIKE PARTICLE-CpG OLIGONUCLEOTIDE VACCINES AND USES THEREOF

Oligonucleotide analogues incorporating 5-aza-cytosine therein

CRISPR/CAS-RELATED METHODS AND COMPOSITIONS FOR TREATING PRIMARY OPEN ANGLE GLAUCOMA

Recombinant virus products and methods for inhibition of expression of DUX4

TRUNCATED TRK B AND TRK C ANTAGONISTS AND USES THEREOF

Treatment using truncated Trk B and Trk C antagonists

Transthyretin (TTR) iRNA compositions and methods of use thereof for treating or preventing TTR-associated diseases

Multivalent oligonucleotide assemblies

Use of inhibitors of leukotriene B4 receptor BLT2 for treating asthma

Methods and compositions for RNA-directed repression of transcription using CRISPR-associated genes

Specific and unique T cell responses and molecular signatures for the treatment and diagnosis of

CaMKK-β as a target for treating cancer

Methods of Producing a Secreted Protein

Small molecule conjugates for intracellular delivery of biologically active compounds

Polycomb-associated non-coding RNAs

Methods of modulating WARS2

Oligomers

METHOD OF TREATING KELOIDS OR HYPERTROPHIC SCARS USING ANTISENSE COMPOUNDS TARGETING CONNECTIVE TISSUE GROWTH FACTOR (CTGF)

REDUCTION OF OFF-TARGET RNA INTERFERENCE TOXICITY

Pharmaceutical composition and method for reducing scar formation

Composition for promoting chondrocyte differentiation or treating cartilage diseases, containing KLF10 expression inhibitor, and method for promoting cartilage differentiation by using same

Dual targeting antisense oligonucleotides as apoptotic inhibtor therapeutic compostions and methods for their use in the treatment of cancer

SGK1 INHIBITORS FOR TREATMENT OF PROSTATE CANCER

Biomarkers and Therapeutic Targets for Sarcoma

RNAi-mediated inhibition of connexin 43 for treatment of IOP-related conditions

ANTISENSE OLIGONUCLEOTIDES FOR INDUCING EXON SKIPPING AND METHODS OF USE THEREOF

ANTISENSE OLIGONUCLEOTIDES FOR INDUCING EXON SKIPPING AND METHODS OF USE THEREOF

BIOLOGICAL MATERIALS AND THERAPEUTIC USES THEREOF

Methods of using an activator of cereblon for neural cell expansion and the treatment of central nervous system disorders

TREATMENT OF NEURODEGENERATIVE AND NEURODEVELOPMENTAL DISEASES BY INHIBITION OF THE a2-Na/K ATPase/a-ADDUCIN COMPLEX

Multi-targeting short interfering RNAs

COMPOSITION FOR REDUCING CELLULAR SENESCENCE LEVEL INCLUDING ACTIVITY INHIBITOR INHIBITING DCUN1D3 ACTIVITY OR EXPRESSION INHIBITOR INHIBITING EXPRESSION OF DCUN1D3-ENCODING GENE AND USE THEREOF

Method for treatment of heart failure

METHOD FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF CANCER METASTASIS

TAILED MIRTRON EFFECTORS FOR RNAI-MEDIATED GENE SILENCING

CD300A RECEPTORS AS VIRUS ENTRY COFACTORS

Methods for treating diet-induced obesity by decreasing or inhibiting P2Y2 purinergic receptor expression or activity

Polycomb-associated non-coding RNAS

Method of treating influenza A

Modified L-Nucleic Acid

Oligonucleotide-ligand conjugates and process for their preparation

Biocompatible flavonoid compounds for organelle and cell imaging

TYROSINE-PHOSPHORYLATED WBP2, A NOVEL CANCER TARGET AND BIOMARKER

RNAi targeting SEC61G

RNAi-Mediated Inhibition of Tumor Necrosis Factor Alpha-Related Conditions

Target point, preparation and method for treating human ADSL deficiency

Double-stranded and single-stranded RNA molecules with 5′ triphosphates and their use for inducing interferon

Antisense polynucleotides to induce exon skipping and methods of treating dystrophies

Modulation of transthyretin expression

Compositions and their uses directed to huntingtin

RNA preparations comprising purified modified RNA for reprogramming cells

Methods and compositions for treating solid tumors and enhancing tumor vaccines

COMPOSITIONS AND METHODS FOR THE TREATMENT AND MANAGEMENT OF STEATOSIS IN HUMAN LIVER

Methods and compositions for neuroprotection

Reagents and Methods for Treating Cancer

Triptolide derivatives and preparation method and use thereof

Polynucleotides and methods for inhibiting cancer cells

DIFFERENTIALLY EXPRESSED MICRORNA MOLECULES FOR THE TREATMENT AND DIAGNOSIS OF CANCER

COMPOSITION INCLUDING RCC1-REGULATING SUBSTANCE FOR REDUCING SENESCENCE OF CELL OR SUBJECT AND METHOD OF REDUCING SENESCENCE OF CELL OR SUBJECT BY USING THE COMPOSITION

In vivo production of small interfering RNAs that mediate gene silencing

Therapeutic targets for cancer progression

TREATMENT OF CARDIAC DISEASES WITH MODULATORS OF THE HIPPO PATHWAY

Control of Varroa mite infestation

SDF-1 binding nucleic acids and the use thereof in cancer treatment

Potent LNA oligonucleotides for the inhibition of HIF-1A expression

RNAi agents, compositions and methods of use thereof for treating transthyretin (TTR) associated diseases

Polycomb-associated non-coding RNAs

Modulation of Exon Recognition in Pre-mRNA By Interfering with the Secondary RNA Structure

Oligonucleotide compounds for targeting huntingtin mRNA

THERAPEUTIC AND DIAGNOSTIC MOLECULES

Polycomb-associated non-coding RNAs

Double stranded oligonucleotide compounds comprising positional modifications

Anionic polyplexes for use in the delivery of nucleic acids

MUCOSAL HEALING PROMOTER

Antisense design

Compositions and methods for inhibiting gene expression of Hif2alpha

Compounds of chemically modified oligonucleotides and methods of use thereof

Modulation of signal transducer and activator of transcription 3 (STAT3) expression

Micro-RNAs and compositions comprising same for the treatment and diagnosis of serotonin-, adrenalin-, noradrenalin-, glutamate-, and corticotropin-releasing hormone- associated medical conditions

Treatment of neurological disorders

Modulation of KCNH2 isoform expression by oligonucleotides as a therapeutic approach for long QT syndrome

Antiviral therapy

Methods and compositions for the specific inhibition of gene expression by double-stranded RNA

MICRORNA MODULATION OF ARTHEROSCLEROSIS AND USES THEREOF

Wound healing compositions and treatments

Method of diagnosis, prognostic or treatment of neurodegenerative disease

Oligonucleotide modulators of the toll-like receptor pathway

Anti-tumor therapy

MiRNA for treating diseases and conditions associated with neo-angiogenesis

STAT3 inhibitors and uses thereof

Chiral nucleic acid adjuvant having immunity induction activity, and immunity induction activator

NUCLEIC ACID CAPABLE OF INHIBITING EXPRESSION OF BETA-2GPI

Materials and methods for modulation of tendon healing

miR-122* as an active micro-RNA, compositions comprising the same and uses thereof

Method of Treatment of Vascular Complications

RNA containing composition for treatment of tumor diseases

Treatment of ocular disorders with anti-connexin proteins and mimetics

Molecular targets for healing or treating wounds

Modulation of synaptic maintenance

SDF-1 binding nucleic acids and the use thereof

Aptamers inhibiting the enzymatic activity of the MMP-9 protein

METHODS AND COMPOSITIONS FOR PANIC DISORDERS

Compositions and methods for treatment of prostate and other cancers

Method for Regulating Cell Proliferation

MicroRNAs and uses thereof

Use of miR-494 to Modulate TRAIL-induced Apoptosis through BIM Down-regulation

Methods and compositions for treating cancer using peptide nucleic acid-based agents

Therapeutic miRNAs for treating heart and skeletal muscle diseases

Treating neurodegenerative disease

METHOD OF INDUCING AN IMMUNE RESPONSE

Methods of polynucleotide preparation using multivalent cation salt compositions

Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response

Inhibitor for inhibiting avian influenza virus and a pharmaceutical composition containing the same

METHOD AND PHARMACEUTICAL COMPOSITION FOR INHIBITING NEURONAL REMODELING

Hippo and dystrophin complex signaling in cardiomyocyte renewal

METHODS FOR TREATING ALLERGIC AIRWAY INFLAMMATION

Nucleic acids encoding peptides for treating wounds, anti-angiogenic compounds and uses thereof

LIVER X RECEPTOR AGONISTS IN THE TREATMENT OF EMPHYSEMA

SiRNA and their use in methods and compositions for inhibiting the expression of the ORAI1 gene

COMPOUNDS AND METHODS FOR MODULATION OF DYSTROPHIA MYOTONICA-PROTEIN KINASE (DMPK) EXPRESSION

High temperature selection of nucleotide-supported carbohydrate vaccines and resulting glycosylated oligonucleotides

Compositions for modulating C9ORF72 expression

Materials and methods for treatment of pulmonary arterial hypertension

Compositions of asymmetric interfering RNA and uses thereof

SiRNA and their use in methods and compositions for inhibiting the expression of the FLAP gene

Cationic lipid

METHOD FOR PREDICTING DEVELOPMENT OF MELANOMA BRAIN METASTASIS

Aptamers to PDGF and VEGF and their use in treating PDGF and VEGF mediated conditions

UCP1 (THERMOGENIN) - INDUCING AGENTS FOR USE IN THE TREATMENT OF A DISORDER OF THE ENERGY HOMEOSTASIS

SnoRNA, compositions and uses

IDENTIFICATION OF A NOVEL B CELL CYTOKINE

Methods for Treating or Preventing Ophthalmological Conditions

Composition comprising a cell sample from a subject with scoliosis and a reagent for detecting PTPμ or PIPK1y

MICRO-RNAS THAT MODULATE LYMPHANGIOGENESIS AND INFLAMMATORY PATHWAYS IN LYMPHATIC VESSEL CELLS

Treatment of pyrroline-5-carboxylate reductase 1 (PYCR1) related disease by inhibition of natural antisense transcript to PYCR1

Compositions and methods for use in treating silicosis and lung cancer

Small interference RNAs, uses thereof and method for inhibiting the expression of PLK1 gene

Mutator Activity Induced by microRNA-155 (miR-155) Links Inflammation and Cancer

Method for preparing nucleic acid aptamer

NUCLEIC ACID LIGANDS TO LL37

USE OF MICRORNA 146-A IN THE DIAGNOSIS, TREATMENT AND PREVENTION OF PICORNAVIRUS INFECTION AND MICRORNA 146-A ANTAGONISTS

GENES OF AN OTITIS MEDIA ISOLATE OF NONTYPEABLE HEAMOPHILUS INFLUENZAE

Methods and compositions for interference with DNA polymerase and DNA synthesis

Antisense composition and method for treating muscle atrophy

MODULATION OF TIMP1 AND TIMP2 EXPRESSION

TARGETING GDF6 AND BMP SIGNALING FOR ANTI-MELANOMA THERAPY

MODULATION OF AXON DEGENERATION

BIOMARKERS FOR THE DIAGNOSIS OF INTERSTITIAL CYSTITIS

Compositions and methods for inhibiting gene expression of factor XII

DNMT inhibitors

Methods and compositions employing an osteopontin aptamer to deliver nucleic acids into smooth muscle, endothelial, cardiac and progenitor/stem cells

METHODS AND COMPOSITIONS FOR MODULATING GENE EXPRESSION USING COMPONENTS THAT SELF ASSEMBLE IN CELLS AND PRODUCE RNAI ACTIVITY

Disulfide-containing alkyne linking agents

COMPOSITIONS AND METHODS FOR MODULATING AUTOPHAGIC CELL DEATH

NTRK2 fusions

COMPOSITIONS AND METHODS RELATING TO C5L2

TYRP1, a natural miRNA sponge, and its use in managing human melanoma aggressiveness

IMPROVED WOUND HEALING COMPOSITIONS AND TREATMENTS

Dynamin 2 inhibitor for the treatment of centronuclear myopathies

Use of microRNA precursors as drugs for inducing CD34-positive adult stem cell expansion

RNA targeting in alpha-synucleinopathies

Compositions and Methods for Inhibiting Expression of Transthyretin

CELL DIFFERENTIATION MARKER AND ITS USES

RNAi-MEDIATED INHIBITION OF SPLEEN TYROSINE KINASE-RELATED INFLAMMATORY CONDITIONS

Hepcidin Binding Nucleic Acids

METHODS AND COMPOSITIONS FOR TREATMENT OF ANGELMAN SYNDROME AND AUTISM SPECTRUM DISORDERS

Methods for inducing cardiomyocyte proliferation

COSTIMULATORY B7-H1 IN RENAL CELL CARCINOMA PATIENTS: INDICATOR OF TUMOR AGGRESSIVENESS AND POTENTIAL THERAPEUTIC TARGET

Treating hepatitis virus infection by modulating microRNAs miR-130a, miR-130b, miR-204, or miR-1236

MicroRNA-Based Methods and Compositions for the Diagnosis, Prognosis and Treatment of Breast Cancer

MODULATION OF EXON RECOGNITION IN PRE-MRNA BY INTERFERING WITH THE SECONDARY RNA STRUCTURE

MicroRNA compounds and methods for modulating miR-122

MicroRNAs modulating the effect of glucocorticoid signaling

THERAPEUTIC COMPOUNDS

Methods and compositions for RNA-guided treatment of HIV infection

Costimulatory B7-H1 in renal cell carcinoma patients: indicator of tumor aggressiveness and potential therapeutic target

Antisense compounds targeting genes associated with cystic fibrosis

Complement component C5 iRNA compositions and methods of use thereof

TARGETING GLIOMA STEM CELLS BY SEQUENCE-SPECIFIC FUNCTIONAL INHIBITION OF PRO-SURVIVAL ONCOMIR-138

TREATING DISEASES ASSOCIATED WITH PGC1-ALPHA BY MODULATING MICRORNAS MIR-130A AND MIR-130B

MicroRNA compounds and methods for modulating miR-21 activity

Bioactive renal cells

Method of inhibiting activation of a T cell by administering an anti-RGM antibody or an RGM siRNA

THERAPEUTIC USES OF MICROVESICLES AND RELATED MICRORNAS

DUAL VECTOR FOR INHIBITION OF HUMAN IMMUNODEFICIENCY VIRUS

RNY-derived small RNAs as biomarkers for atherosclerosis-related disorders

Modeling and Predicting Differential Alternative Splicing Events and Applications Thereof

Modulation of apolipoprotein C-III expression

Inhibitors of CACNA1A/ALPHA1A subunit internal ribosomal entry site (IRES) and methods of treating spinocerebellar ataxia type 6

TOLEROGENIC DENDRITIC CELLS TO TREAT INFLAMMATORY BOWEL DISEASE

RNA INTERFERENCE SUPPRESSION OF NEURODEGENERATIVE DISEASES AND METHODS OF USE THEREOF

METHOD OF TREATING AND PROGNOSING SCOLIOTIC PATIENT SUBGROUPS

DIAGNOSIS, PROGNOSIS AND TREATMENT OF GLIOBLASTOMA MULTIFORME

Anti-tumor therapy

NUCLEIC ACID MOLECULE FOR INHIBITING ACTIVITY OF RNAI MOLECULE

Compositions and methods related to miRNA modulation of neovascularization or angiogenesis

Gene expression and pain

ATRX AS A COMPANION DIAGNOSTIC FOR CDK4 INHIBITORS

Kits for classifying a subject having or at risk for developing idiopathic scoliosis

Methods for Diagnosing Prostate Cancer Using MicroRNAs

UNA OLIGOMER ACTIVE STRUCTURES FOR THERAPEUTIC AGENTS

METHODS OF MODULATING LYMPHANGIOGENESIS, E.G., TO TREAT CORNEAL TRANSPLANT REJECTION, IN A SUBJECT

Organic compounds to treat hepatitis B virus

THERAPEUTIC COMPOSITIONS AND METHODS FOR MALIGNANT TUMORS WITH RNAI MOLECULES TARGETED TO HSP47 AND P21

Methods of diagnosing, classifying and treating endometrial cancer and precancer

Use of RHOA in cancer diagnosis and inhibitor screening

RNA interference agents for GST-PI gene modulation

Targeting microRNAs for metabolic disorders

miR-92 inhibitors and uses thereof

RNA interference agents for P21 gene modulation

RNA agents for P21 gene modulation

RNA agents for GST-Pi gene modulation

Therapeutic agent for corneal epithelial disorder

METHODS OF USE OF SPHINGOLIPID POLYALKYLAMINE OLIGONUCLEOTIDE COMPOUNDS

USE OF NUCLEIC ACIDS WITH REDUCED PRESSURE THERAPY

METHODS AND COMPOSITIONS FOR ENHANCING DELIVERY OF DOUBLE-STRANDED RNA OR A DOUBLE-STRANDED HYBRID NUCLEIC ACID TO REGULATE GENE EXPRESSION IN MAMMALIAN CELLS

Acellular pro-inflammatory compositions, process for making same and methods of using same

Nanocomplexes for co-delivering a drug and siRNA and uses thereof

Method of treating pain with an antibody against netrin-4, Unc5B or neogenin

COMPOSITIONS AND METHODS FOR MODULATING EXPRESSION OF FRATAXIN

Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response

Micro-RNA regulation of bone loss

Methods, systems, and compositions relating to miRNA-146a

METHOD FOR THE TREATMENT OF FIBROTIC DISEASE

COMPOSITIONS AND METHODS FOR TREATING ANAPLASTIC THYROID CANCER

Methods for treating ischemia-reperfusion injury

Methods and compositions for selecting siRNA of improved functionality

Compositions and methods for inhibiting expression of mutant EGFR gene

Ligase E3 RNF185 inhibitors and uses thereof

Methods of identifying and treating poor prognosis cancers

SPHERICAL NUCLEIC ACID-BASED CONSTRUCTS AS IMMUNOREGULATORY AGENTS

G-rich isoDNA sequences forming G-quadruplex structure, their function as aptamers and a process for the preparation thereof

Compounds and methods for modulating target nuclear and sub-nuclear nucleic acid molecules in cells and animals

Compounds and methods for modulating target nuclear and sub-nuclear nucleic acid molecules in cells and animals

Methods for treating and/or limiting development of diabetes

Methods for Modulation of Autophagy Through the Modulation of Autophagy-Inhibiting Gene Products

Novel linker, preparation method, and application thereof

Antisense oligonucleotides with improved pharmacokinetic properties

Methods for treating and/or limiting development of diabetes

THERAPEUTIC TREATMENT FOR DRUG POISONING AND ADDICTION

Modified nucleosides, analogs thereof and oligomeric compounds prepared therefrom

Methods and Compositions for the Treatment of Prostate Related Disorders using miR-1

Methods and compositions for treating malignant tumors associated with KRAS mutation

RNA interference compositions and methods for malignant tumors

Composition for reducing senescence of cell or subject comprising smurf2 inhibitor and use thereof

Spherical nucleic acid-based constructs as immunostimulatory agents for prophylactic and therapeutic use

Methods and compositions for the specific inhibition of beta-catenin by double-stranded RNA

C-myc antisense oligonucleotides and methods for using the same to treat cell-proliferative disorders

AGENTS AND METHODS FOR INHIBITING MIR-148A FOR THE MODULATION OF CHOLESTEROL LEVELS

PEPTIDE-AND AMINE-MODIFIED GLUCAN PARTICLES FOR DELIVERY OF THERAPEUTIC CARGOES

Fidgetin-like 2 as a target to enhance wound healing

Organic small hairpin RNAs

Conserved HBV and HCV sequences useful for gene silencing

Therapeutic polynucleotides, compositions, and methods

Antisense oligonucleotides (ODN) against Smad7 and uses thereof in medical field

Methods of Inhibiting Tumorigenesis in Colon Adenocarcinoma and Compositions Therefor

Antisense molecules for treatment of infection

RNA with a combination of unmodified and modified nucleotides for protein expression

METHODS FOR DETECTING AND MODULATING THE SENSITIVITY OF TUMOR CELLS TO ANTI-MITOTIC AGENTS AND FOR MODULATING TUMORIGENICITY